Requires health insurance coverage for coronary artery calcium screening under certain circumstances.
Summary
S4122 would require a broad set of New Jersey health coverage arrangements to pay for coronary artery calcium (CAC) screening when certain criteria are met. The mandate applies to hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health maintenance organization enrollee agreements, individual and small employer health benefits plans, and the State Health Benefits Program and School Employees’ Health Benefits Program. Coverage would be required for a person age 45 or older, or for a person determined by a health care provider to have intermediate risk of coronary heart disease based on an evidence-based cardiovascular risk algorithm, including a pooled cohort equation.
The bill specifies that the screening benefit must be provided at least once every five years, unless a provider determines more frequent screening is medically necessary because of an underlying condition. The screening must be covered to the same extent as other medical conditions under the applicable contract or plan, and the mandate would apply to policies and contracts issued, renewed, or otherwise in force on or after the effective date. In practical terms, the bill adds CAC screening to the list of covered preventive or diagnostic services that insurers and public employee health programs must reimburse under New Jersey law.
Impact
The bill would amend and supplement multiple New Jersey insurance statutes by imposing a uniform CAC screening coverage requirement across nearly all major private and public health coverage categories regulated by the Department of Banking and Insurance. It would affect insurers, hospital and medical service corporations, HMOs, and state-administered health benefits programs, requiring them to cover the cost of the screening for eligible enrollees and subscribers. Because the mandate applies to policies and contracts delivered, issued, executed, or renewed on or after the effective date, it would become part of the standard benefit structure for future coverage cycles.
Sentiment
Based on the bill text and the absence of committee transcripts or recorded votes, the available record suggests a straightforward, pro-coverage policy approach with no documented opposition in the materials provided. The bill is framed as a health access measure aimed at earlier detection of coronary disease risk, and its structure indicates an intent to standardize coverage rather than leave screening decisions entirely to plan discretion. No formal sentiment from hearings or floor debate is available in the supplied context.
Contention
The main policy issue likely to generate debate is the scope of the insurance mandate: the bill requires coverage for a specific cardiac screening across many plan types, which could raise concerns about added premium costs, utilization, and medical necessity standards. Another possible point of contention is the age threshold and risk-based trigger, since the bill covers people age 45 and older as well as younger people with intermediate cardiovascular risk determined by a provider using an evidence-based algorithm. Supporters would likely emphasize preventive care and early detection, while insurers or cost-conscious stakeholders may question whether the mandate is broad enough, too broad, or whether the five-year interval should be more flexible. However, no specific opposing arguments are documented in the provided record.